In part 3 of the MedEvidence Diabetes series Dr. Koren and Sharon Smith discuss choosing drug classes for diabetes, weight loss and cardiovascular health.
💉GLP-1 Drug Class
💉SGLT2i Drug Class
🔬 Past and New Clinical Research Trials
Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.
Sharon Smith, RN, CDCES is the VP of Recruitment at ENCORE Research Group, and a Diabetic Educational Nurse with a passion for educating patients as well as staff on healthy lifestyle options without giving up on special treats.
Additional podcasts on Diabetes:
Diabetes 101 - https://www.buzzsprout.com/1926091/11699808-diabetes-101.mp3?download=true
Let’s Talk Diabetes - https://www.buzzsprout.com/1926091/11743340
A Deep Dive into Diabetes Stories & Anecdote - https://www.buzzsprout.com/1926091/11744476-a-deep-dive-into-diabetes-stories-anecdote.mp3?download=true
Diabetic Epidemic - https://www.buzzsprout.com/1926091/11744765-diabetic-epidemic.mp3?download=true
Rate, Review and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.
Follow MedEvidence! on Social Media to discover the Truth Behind the Data.
Facebook
Instagram
Twitter
LinkedIn
Powered by ENCORE Research Group at www.ENCOREDOCS.com
Original Air Date: November 11, 2022
#demandfordata #medevidence #diabetes #medicalnews #clinincalresearch #diabeticdrugs #CGM #continuousglucosemonitor #bloodsugar
